BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17533052)

  • 61. Subcellular localization of the oncoprotein MTG8 (CDR/ETO) in neural cells.
    Sacchi N; Tamanini F; Willemsen R; Denis-Donini S; Campiglio S; Hoogeveen AT
    Oncogene; 1998 May; 16(20):2609-15. PubMed ID: 9632137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncogenic potential of the RUNX gene family: 'overview'.
    Ito Y
    Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells.
    Dobbin E; Corrigan PM; Walsh CP; Welham MJ; Freeburn RW; Wheadon H
    Leuk Res; 2008 Oct; 32(10):1554-64. PubMed ID: 18355917
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.
    Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR
    Blood; 1998 May; 91(9):3134-43. PubMed ID: 9558367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1-ETO fusion protein in Notch1-immortalized HSCN1cl10 cells.
    Delaney C; Bernstein ID
    Br J Haematol; 2004 May; 125(3):353-7. PubMed ID: 15086416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation.
    Ohno S; Sato T; Kohu K; Takeda K; Okumura K; Satake M; Habu S
    Int Immunol; 2008 Jan; 20(1):71-9. PubMed ID: 18003603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis.
    Pick M; Azzola L; Mossman A; Stanley EG; Elefanty AG
    Stem Cells; 2007 Sep; 25(9):2206-14. PubMed ID: 17556598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells.
    Lengerke C; McKinney-Freeman S; Naveiras O; Yates F; Wang Y; Bansal D; Daley GQ
    Ann N Y Acad Sci; 2007 Jun; 1106():197-208. PubMed ID: 17303828
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult.
    Motoda L; Osato M; Yamashita N; Jacob B; Chen LQ; Yanagida M; Ida H; Wee HJ; Sun AX; Taniuchi I; Littman D; Ito Y
    Stem Cells; 2007 Dec; 25(12):2976-86. PubMed ID: 17823240
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
    Lam K; Zhang DE
    Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
    Osato M
    Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
    Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
    PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls.
    Tian X; Kaufman DS
    Curr Opin Hematol; 2008 Jul; 15(4):312-8. PubMed ID: 18536568
    [TBL] [Abstract][Full Text] [Related]  

  • 75. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
    Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
    Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
    Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
    Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation of skeletal development by the Runx family of transcription factors.
    Komori T
    J Cell Biochem; 2005 Jun; 95(3):445-53. PubMed ID: 15786491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain.
    Wei H; Liu X; Xiong X; Wang Y; Rao Q; Wang M; Wang J
    FEBS Lett; 2008 Jun; 582(15):2167-72. PubMed ID: 18519037
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression.
    Kärner E; Unger C; Cerny R; Ahrlund-Richter L; Ganss B; Dilber MS; Wendel M
    J Cell Physiol; 2009 Feb; 218(2):323-33. PubMed ID: 18932205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.